Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Down 96.4% in April

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 400 shares, a decline of 96.4% from the March 31st total of 11,000 shares. Based on an average daily volume of 40,900 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Bluejay Diagnostics Stock Performance

BJDX stock remained flat at $0.55 during mid-day trading on Thursday. 19,115 shares of the company’s stock traded hands, compared to its average volume of 45,677. Bluejay Diagnostics has a 52-week low of $0.47 and a 52-week high of $13.98. The business has a fifty day simple moving average of $0.75 and a 200 day simple moving average of $1.87. The company has a market cap of $1.48 million, a price-to-earnings ratio of -0.06 and a beta of 0.85.

Bluejay Diagnostics (NASDAQ:BJDX) last posted its quarterly earnings results on Thursday, March 28th. The company reported ($1.78) EPS for the quarter, missing analysts’ consensus estimates of ($0.68) by ($1.10).

Institutional Investors Weigh In On Bluejay Diagnostics

An institutional investor recently bought a new position in Bluejay Diagnostics stock. Sabby Management LLC purchased a new position in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 21,221 shares of the company’s stock, valued at approximately $92,000. Sabby Management LLC owned approximately 1.71% of Bluejay Diagnostics at the end of the most recent quarter. 18.47% of the stock is owned by institutional investors.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.